In vivo screening reveals new regulators of natural killer cell development and functional response to acute cytomegalovirus infection
Natural killer (NK) cells are critical innate immune effectors in antiviral and antitumor responses. However, the factors governing NK cell development and function remain incompletely understood. To address this, we adopted an in vivo screening approach, generating a panel of mice deficient in genes differentially expressed across NK cell maturation stages or following viral infection. We performed a combinational screen comprising baseline immunophenotyping and mouse cytomegalovirus (MCMV) challenge. We identified regulators of NK cell development, including transcriptional regulators and proteins with putative trafficking functions. MCMV challenge studies additionally identified proteins that affected antiviral immunity independently of NK cell phenotypes, including a previously undescribed regulator of NK cell degranulation, synaptotagmin-like protein 3. Identified genes exhibited a trend toward reduced tolerance to loss of function in large-scale human sequencing studies and evidence for reduced NK cell numbers in a cohort of patients with immunodeficiency. Together, these findings provide a resource of NK-expressed genes important for NK cell maturation and function, with relevance to human health.
Authors
- Mathew Clement (ORCID: https://orcid.org/0000-0002-9280-5281)
- Matthew Cook (ORCID: https://orcid.org/0000-0002-3331-9363)
- Carmen Ballesteros Reviriego (ORCID: https://orcid.org/0009-0002-4999-0896)
- Katherine Harcourt (ORCID: https://orcid.org/0009-0000-5963-1884)
- Daniel M. Davis (ORCID: https://orcid.org/0000-0002-9182-291X)
- Louise van der Weyden (ORCID: https://orcid.org/0000-0002-0645-1879)
- Ian Robert Humphreys (ORCID: https://orcid.org/0000-0002-9512-5337)
- Sam Sheppard (ORCID: https://orcid.org/0000-0002-1420-6910)
- Eddie C. Y. Wang (ORCID: https://orcid.org/0000-0002-2243-4964)
- Cordelia Brandt
- Roseanna K. Hare (ORCID: https://orcid.org/0000-0001-8974-2489)
- Paul Lyons (ORCID: https://orcid.org/0000-0001-7035-8997)
- Lucy Chapman (ORCID: https://orcid.org/0000-0002-2358-9562)
- Eleanor J. Pring (ORCID: https://orcid.org/0000-0002-4816-9169)
- Morgan Marsden (ORCID: https://orcid.org/0009-0008-1939-6072)
- Anneliese O. Speak (ORCID: https://orcid.org/0000-0003-4890-4685)
- Bushra Abu-Helil (ORCID: https://orcid.org/0009-0006-5333-9018)
- Agnieszka Andres (ORCID: https://orcid.org/0009-0003-4592-4063)
- David J. Adams (ORCID: https://orcid.org/0000-0001-9490-0306)
- V Iyer (ORCID: https://orcid.org/0000-0002-7536-0954)
- Maria A Oliver (ORCID: https://orcid.org/0000-0002-1062-6387)
- Simon Clare (ORCID: https://orcid.org/0009-0006-9331-2071)
Institutions
- University of Cambridge (GB)
- Wellcome Sanger Institute (GB)
- University of Manchester (GB)
- Imperial College London (GB)
- Cardiff University (GB)
Publication Details
- Journal
- Science Advances
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1126/sciadv.aeh5393
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- Health and Care Research Wales
- National Institute for Health and Care Research
- Royal Society
- Kidney Research UK
- University of Cambridge
- Cardiff University
- Medical Research Council
- NIHR Cambridge Biomedical Research Centre